ELN-154088(ELN-154088) - _专利_临床

概要

基本信息

药物类型

小分子化药

别名

ELN 154088

靶点-

作用机制-

治疗领域

神经系统疾病

在研适应症-

非在研适应症

疼痛

原研机构

Perrigo Co. Plc

在研机构-

非在研机构

Perrigo Co. Plc

Elan Corp.

最高研发阶段终止临床2期

首次获批日期-

最高研发阶段(中国)-

特殊审评-

登录后查看时间轴

关联

3

项与 ELN-154088 相关的临床试验

NCT02244762 / Completed临床1期

Evaluation of the Effect of Renal Impairment on the Pharmacokinetics and Metabolism of Hydrocodone and Its Metabolites Following Administration of Hydrocodone Bitartrate Extended-Release (HC-ER) 20 mg Capsules

Determine the influence of renal impairment on the pharmacokinetics and metabolism of Hydrocodone Bitartrate Extended-Release (HC-ER) 20 mg capsules

开始日期2011-02-01

申办/合作机构

Zogenix, Inc.

NCT02242734 / Completed临床1期

Evaluation of the Effect of Hepatic Impairment on the Pharmacokinetics and Metabolism of Hydrocodone and Its Metabolites Following Administration of Hydrocodone Bitartrate Extended-Release (HC-ER) 20mg Capsules

Determine the influence of hepatic impairment on the pharmacokinetics and metabolism of Hydrocodone Bitartrate Extended-Release (HC-ER) 20 mg capsules

开始日期2011-02-01

申办/合作机构

Zogenix, Inc.

NCT02197156 / Completed临床2期

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Active Comparator Study of Hydrocodone Bitartrate Extended Release (HC-ER) in Adults Following Bunionectomy Surgery

The purpose of the study is to establish a dose-response relationship among several capsule strengths of Hydrocodone Bitartrate Extended Release (HC-ER) and to compare the efficacy to placebo following bunionectomy surgery

开始日期2002-08-01

申办/合作机构

Zogenix, Inc.

100 项与 ELN-154088 相关的临床结果

登录后查看更多信息

100 项与 ELN-154088 相关的转化医学

登录后查看更多信息

100 项与 ELN-154088 相关的专利（医药）

登录后查看更多信息

100 项与 ELN-154088 相关的药物交易

登录后查看更多信息